2520-1026

BMC Rheumatology

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 316 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact316 DOIs
2

Add abstracts to 270 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact270 DOIs
3

Deposit reference lists for 20 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact20 DOIs

DOIs for this ISSN

Showing the top 5 of 658 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Giant cell arteritis: pathogenic mechanisms and new potentia… (10.1186/s41927-017-0004-5)
Abstract ORCID License
126.09 47
2 A phase II trial protocol of Tocilizumab in anti-TNF refract… (10.1186/s41927-018-0010-2)
Abstract ORCID License
111.85 30
3 Cytokines in the pathogenesis of rheumatoid arthritis: new p… (10.1186/s41927-017-0001-8)
Abstract License
105.19 126
4 Network meta-analysis and cost per responder of targeted Imm… (10.1186/s41927-018-0011-1)
Abstract ORCID License
88.21 14
5 The utility of ESR, CRP and platelets in the diagnosis of GC… (10.1186/s41927-019-0061-z)
Abstract ORCID
85.80 51
6 Real world long-term impact of intensive treatment on diseas… (10.1186/s41927-019-0054-y)
Abstract ORCID
78.41 36
7 The role of vitamin D testing and replacement in fibromyalgi… (10.1186/s41927-018-0035-6)
Abstract ORCID
77.82 35
8 Methotrexate therapy impacts on red cell distribution width… (10.1186/s41927-018-0012-0)
Abstract ORCID License
75.00 9
9 Immunoglobulin abnormalities are frequent in patients with l… (10.1186/s41927-019-0079-2)
Abstract ORCID
73.86 29
10 Perioperative medical management for patients with RA, SPA,… (10.1186/s41927-018-0008-9)
Abstract License
73.12 28
11 A technology-enabled Counselling program versus a delayed tr… (10.1186/s41927-017-0005-4)
Abstract ORCID License
71.57 8
12 The C-reactive protein (CRP)-albumin-lymphocyte (CALLY) inde… (10.1186/s41927-025-00499-7)
Abstract ORCID
65.05 19
13 In vitro and in vivo characterization of the JAK1 selectivit… (10.1186/s41927-018-0031-x)
Abstract
63.79 355
14 Rheumatoid Arthritis Portrayal by UK National Newspapers 201… (10.1186/s41927-018-0013-z)
Abstract ORCID License
63.38 6
15 Evaluation of hematological markers as prognostic tools in r… (10.1186/s41927-024-00444-0)
Abstract ORCID
62.76 17
16 Relapse rates after elective discontinuation of anti-TNF the… (10.1186/s41927-019-0058-7)
Abstract ORCID
61.52 16
17 The underrated prevalence of depression in Japanese patients… (10.1186/s41927-017-0003-6)
Abstract License
58.80 14
18 Vitamin D in individuals before onset of rheumatoid arthriti… (10.1186/s41927-018-0033-8)
Abstract ORCID
58.80 14
19 Patient-centred standards of care for adults with myositis (10.1186/s41927-017-0002-7)
Abstract ORCID License
58.36 5
20 Effectiveness and cost-effectiveness of the modified Pilates… (10.1186/s41927-018-0051-6)
Abstract ORCID
57.31 13
21 Radiographic progression in early rheumatoid arthritis patie… (10.1186/s41927-018-0009-8)
Abstract License
55.70 12
22 Demography, baseline disease characteristics, and treatment… (10.1186/s41927-018-0034-7)
Abstract ORCID
55.70 12
23 How do patients with systemic autoimmune rheumatic disease p… (10.1186/s41927-018-0017-8)
Abstract ORCID
53.96 11
24 Infection versus disease activity in systemic lupus erythema… (10.1186/s41927-024-00395-6)
Abstract ORCID
52.07 10
25 Cardiovascular co-morbidity in patients with rheumatoid arth… (10.1186/s41927-018-0014-y)
Abstract
51.98 119
26 Living with osteoarthritis is a balancing act: an exploratio… (10.1186/s41927-018-0023-x)
Abstract
50.00 99
27 Health-related quality of life in patients with rheumatoid a… (10.1186/s41927-019-0080-9)
Abstract
47.71 80
28 Norwegian society of rheumatology recommendations on diagnos… (10.1186/s41927-024-00422-6)
Abstract ORCID
47.71 8
29 Terminologies and definitions used to classify patients with… (10.1186/s41927-025-00482-2)
Abstract ORCID
47.71 8
30 General practitioners’ views on managing knee osteoarthritis… (10.1186/s41927-018-0037-4)
Abstract
46.43 71
31 A systematic review of guidelines for managing rheumatoid ar… (10.1186/s41927-019-0090-7)
ORCID
45.15 63
32 Rheumatoid arthritis and COVID-19 outcomes: a systematic rev… (10.1186/s41927-024-00431-5)
Abstract ORCID
45.15 7
33 Efficacy and safety of baricitinib in rheumatoid arthritis p… (10.1186/s41927-024-00446-y)
Abstract ORCID
45.15 7
34 Sociodemographic and economic barriers to initial specialist… (10.1186/s41927-025-00501-2)
Abstract ORCID
45.15 7
35 Comparative study of Interleukin-18 (IL-18) serum levels in… (10.1186/s41927-019-0053-z)
Abstract
43.90 56
36 Socioeconomic status, reserve capacity, and depressive sympt… (10.1186/s41927-024-00416-4)
Abstract ORCID
42.25 6
37 Impact of vitamin D supplementation on disease activity and… (10.1186/s41927-025-00543-6)
Abstract ORCID
42.25 6
38 Identifying the unmet information and support needs of women… (10.1186/s41927-018-0029-4)
Abstract
41.80 46
39 Trends in incidence, mortality, and causes of death associat… (10.1186/s41927-018-0043-6)
Abstract
41.80 46
40 Vitamin D supplementation in systemic lupus erythematosus: r… (10.1186/s41927-021-00223-1)
ORCID
41.57 45
41 A proteomic analysis of serum-derived exosomes in rheumatoid… (10.1186/s41927-018-0041-8)
Abstract
41.33 44
42 Interpretation of DAS28 and its components in the assessment… (10.1186/s41927-018-0016-9)
Abstract
40.32 40
43 Trends in diagnostic prevalence and treatment patterns of ma… (10.1186/s41927-019-0086-3)
ORCID
40.05 39
44 The extra-articular impacts of rheumatoid arthritis: moving… (10.1186/s41927-018-0039-2)
Abstract
39.21 36
45 The multifaceted impact of anxiety and depression on patient… (10.1186/s41927-019-0092-5)
ORCID
39.21 36
46 Initial seronegative immune-mediated necrotising myopathy wi… (10.1186/s41927-020-00128-5)
Abstract ORCID
38.91 5
47 Characterization of sleep disturbance in established rheumat… (10.1186/s41927-024-00405-7)
Abstract ORCID
38.91 5
48 Effects of tofacitinib on bone turnover markers and bone mod… (10.1186/s41927-024-00414-6)
Abstract ORCID
38.91 5
49 Efficacy and safety of upadacitinib, a selective JAK-1 inhib… (10.1186/s41927-025-00467-1)
Abstract ORCID
38.91 5
50 Living life precariously with rheumatoid arthritis - a mega-… (10.1186/s41927-018-0049-0)
Abstract
38.60 34